Fred Sorenson MSc, Senior Business Development Manager, has more than 30 years of experience working on behalf of the pharmaceutical and medical device industries. He began in the business by working in the field of health economics and was one of the co-authors of “EUROCARE”, a book that systematically examined the health care systems of 5 European countries. During this time he also assisted in building medical expert systems such as DOC (“Doctor’s Office Computer” system) and creating medical and biostatistical models including COMCON (Computer for Medical Congresses), a state-of-the-art scientific database and interactive tool on antibiotics that was sold in over 50 countries, and also worked on creating some of the very first global value dossiers.
Apart from this health economic background, for most of his career Fred has mainly been involved with designing, running, analyzing and reporting on the results of clinical trials, especially the late-phase studies that help provide additional evidence for effective treatment as well as reimbursement, including economic elements such as resource utilization and Quality of Life. In this regard, he has worked in a wide variety of capacities including biostatistician, data manager, auditor, medical writer and project manager for a broad range of drugs/devices and indications. Another area that distinguishes Fred is his interest in performing clinical studies in less developed countries and as a result has worked in diseases such as malaria, tuberculosis, leprosy and HIV in Africa, Asia & Latin America.
Prior to joining Xcenda on a consultancy basis, supporting global health economics and outcomes research, Fred most notably served for more than 13 years as General Manager of the European office of an international evidence-based research company (Analytica International, formerly IMOR) that he co-founded and led with a peak staff of over 45 persons, in addition to being mainly responsible for global business development within the entire organization. Apart from managerial responsibilities, Fred also ran the clinical trials group that mainly worked on Phase IIIb / IV studies. In the midst of Fred’s tenure at IMOR/Analytica, he helped to found the “Cardiac Research Unit”, a site-management organization at the renowned Heart and Diabetes Center in Bad Oeynhausen, Germany that provided on-site assistance for virtually all ongoing clinical studies and registries (ca. 30 per year). Prior to that Fred worked for 10 years at the Institute for Medical Informatics and Biostatistics (IMIB) in Switzerland where he was Vice President and Head of Biostatistics.
Fred received his BSc in both Psychology and Philosophy from the University of Southern Colorado and did his post-graduate work in Sociology and Economics (Thesis on “Registration of Vital Birth Statistics in Nepal”) at the University of Basel in Switzerland. Among various associations, he is an active member of International Society of Pharmacoeconomics and Outcomes Research (ISPOR), serves on the board of the Basel Biometric Society (BBS) and is one of 2 Swiss representatives to the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) where he chaired the External Affairs committee.